Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Journal of the American College of Cardiology|August 13, 2016
Bioabsorbable Intracoronary Matrix for Prevention of Ventricular Remodeling After Myocardial InfarctionSunil V Rao, Uwe Zeymer, Pamela S Douglas, et al.
JAMA|March 28, 2026
Evolocumab to Reduce First Major Cardiovascular Events in Patients Without Known Significant Atherosclerosis and With Diabetes: Results From the VESALIUS-CV TrialNicholas A Marston, Erin A Bohula, Ajay K Bhatia, et al.
Cannabis and Cannabinoid Research|July 21, 2022
Cannabinoids to Improve Health-Related Quality of Life in Patients with Neurological or Oncological Disease: A Meta-AnalysisVera Belgers, Jantine G Röttgering, Linda Douw, et al.
The American Journal of Medicine|January 3, 2015
Late Consequences of Acute Coronary Syndromes: Global Registry of Acute Coronary Events (GRACE) Follow-upSami M A Alnasser, Wei Huang, Joel M Gore, et al.
European Heart Journal|August 30, 2020
Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)Nadia Bouabdallaoui, Jean-Claude Tardif, David D Waters, et al.
European Journal of Heart Failure|April 1, 2010
Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European Society of Cardiology and endorsed by the European Society of Intensive Care MedicineMihai Gheorghiade, Ferenc Follath, Piotr Ponikowski, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|May 15, 2020
Cost-effectiveness of low-dose colchicine after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)Michelle Samuel, Jean-Claude Tardif, Paul Khairy, et al.
The New England Journal of Medicine|August 31, 2016
Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa InhibitorsStuart J Connolly, Truman J Milling, John W Eikelboom, et al.
JAMA Cardiology|September 21, 2022
Complete Revascularization vs Culprit Lesion-Only Percutaneous Coronary Intervention for Angina-Related Quality of Life in Patients With ST-Segment Elevation Myocardial Infarction: Results From the COMPLETE Randomized Clinical TrialShamir R Mehta, Jia Wang, David A Wood, et al.
Circulation|August 30, 2022
Randomized, Placebo-Controlled Phase 2b Study to Evaluate the Safety and Efficacy of Recombinant Human Lecithin Cholesterol Acyltransferase in Acute ST-Segment-Elevation Myocardial Infarction: Results of REAL-TIMI 63BMarc P Bonaca, David A Morrow, Brian A Bergmark, et al.
Pageof 8